Peanut allergy is a potentially severe and lifelong allergy, with few effective treatments or preventative measures.
To convene an expert panel of allergists, pediatricians, and advocates to discuss and highlight unmet needs in the prevention and management of peanut allergies.
Literature searches of PubMed were performed. The panel evaluated published data on the prevention of peanut allergy, treatment of existing peanut allergy, and management of reactions following unintentional peanut exposures.
Key unmet needs in the prevention and management of peanut allergy were identified, including: 1) enhancing and optimizing implementation of early peanut introduction as a means of preventing the development of peanut allergy; 2) developing knowledge translation strategies regarding the safety and efficacy data for current and emerging immunotherapies for peanut-allergic children to support their use in clinical practice; and 3) promoting understanding of true exposure risk in allergic individuals and ensuring access to epinephrine for accidental exposures that provoke severe reactions. Clinicians should help educate caregivers about the actual risks associated with peanut allergy, and its prevention and management so that treatment decisions can be evidence based rather than fear based. Support tools are needed to help address caregiver goals, expectations, and psychological barriers, as well as identify facilitators for prevention and treatment strategies.
There are significant unmet needs in our understanding of peanut allergy; addressing these needs will help to enhance understanding of how to most effectively prevent and treat peanut allergy, as well as educate the food-allergic and nonallergic community regarding current evidence-based practices.
Copyright © 2020. Published by Elsevier Inc.